If you need more lookups,
subscriptions start at $34 USD/month.
Arun Prasath Location
Fort Lauderdale, FL, US
Arun Prasath Work
2026 -now Global Chief Scientific Officer @
2022 -2026 Senior Vice President, R and D @
2017 -2021 Vice President, Global R and D, Apotex @
2016 -2017 Director, Product Development @
2014 -2016 Director, Product Development @
2010 -2014 Associate Director, Product Development @ Actavis
2010 -2014 Associate Director, Product Development @ Actavis
2008 -2010 Principal Scientist, Product Development @ Watson Pharmaceuticals, Florida, U.S.A
2008 -2008 Principal Scientist, Product Development @
2004 -2008 Senior Scientist, Product Development @
2003 -2004 Research Officer, Formulations R and D @
2002 -2003 Formulation Development Executive, Formulations R and D @
2001 -2002 Formulation Development Pharmacist, Formulation R and D @
Arun Prasath Education
J.S.S College of Pharmacy, Ooty, India
Master of Pharmacy (M. Pharm) (Pharmaceutics)
1999-2001
J.S.S College of Pharmacy, Ooty, India, Tamil Nadu M.G.R Medical University
Bachelor of Pharmacy (B.Pharm.)
1995-1999
Arun Prasath Skills
R&D
Product Development
GMP
Pharmaceutical Industry
Formulation
Standard Operating Procedure (SOP)
Research and Development (R&D)
Microsoft Office
Management
Customer Service
Strategic Planning
Strategy
Research and Development R&d
Standard Operating Procedure Sop
Research and Development
Standard Operating Procedure
Arun Prasath Summary
Arun Prasath, based in Fort Lauderdale, FL, US, is currently a Global Chief Scientific Officer at Cadila Pharmaceuticals Limited. Arun Prasath brings experience from previous roles at Cipla, Apotex Corp., Teva Pharmaceuticals and Actavis (now Allergan). Arun Prasath holds a 1999 - 2001 Master of Pharmacy (M. Pharm) in Pharmaceutics @ J.S.S College of Pharmacy, Ooty, India. With a robust skill set that includes R&D, Product Development, GMP, Pharmaceutical Industry, Formulation and more. Arun Prasath has 2 emails on RocketReach.
Looking for a different Arun Prasath?
Find contact details for 700 million professionals.